<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buske, C.</style></author><author><style face="normal" font="default" size="100%">Leblond, V.</style></author><author><style face="normal" font="default" size="100%">Dimopoulos, M.</style></author><author><style face="normal" font="default" size="100%">Kimby, E.</style></author><author><style face="normal" font="default" size="100%">Jäger, U.</style></author><author><style face="normal" font="default" size="100%">Dreyling, M.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Waldenström's macroglobulinaemia: ESMO clinical practice guidelines for diagnosis, treatment and follow-up</style></title><secondary-title><style face="normal" font="default" size="100%">Annals of Oncology</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-84885353808&amp;doi=10.1093%2fannonc%2fmdt298&amp;partnerID=40&amp;md5=d5950b8f912e4f472b8e031e6a7b0f60</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">24</style></volume><pages><style face="normal" font="default" size="100%">vi155 - vi159</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><issue><style face="normal" font="default" size="100%">SUPPL.6</style></issue><notes><style face="normal" font="default" size="100%">Cited By :13Export Date: 21 February 2017</style></notes></record></records></xml>